Archive: 31/10/2016
Results from the BIO-RESORT trial presented
Results of a large-scale, multicenter study found that treatment with two thin-strut drug-eluting stents were both non-inferior to a durable polymer drug-eluting stent and showed favorable clinical outcomes at one year in ...
Oct 31, 2016
Two-year results from the LEADERS FREE trial presented
The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high bleeding risk patients treated with one month of dual antiplatelet therapy (DAPT), found that a polymer-free drug-coated stent ...
Oct 31, 2016
Results from the BIONICS trial reported
The large multinational randomized BIONICS study found that a novel ridaforolimus-eluting stent (BioNIR) was non-inferior to a zotarolimus-eluting stent (Resolute) for one-year clinical outcomes in a broad, less selected ...
Oct 31, 2016
Stents, bypass surgery equally safe and effective for many with left main heart disease
A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.
Oct 31, 2016
Results of ILUMIEN III trial presented
Although percutaneous coronary intervention (PCI) is most commonly guided by angiography alone, results from a new study investigating adjunctive imaging modalities showed that the use of a novel optical coherence tomography ...
Oct 31, 2016